{{Drugbox
| verifiedrevid = 477242061
| IUPAC_name = 6-[3-(1-adamantyl)-4-methoxy-phenyl] naphthalene-2-carboxylic acid
| image = Adapalene2DACS.svg
| width = 230px
| image2 = Adapalene3Dan.gif
| width2 = 250px

<!--Clinical data-->
| tradename = Differin, Teva, Pimpal, Gallet, Adelene, Adeferin
| Drugs.com = {{drugs.com|monograph|adapalene}}
| MedlinePlus = a604001
| licence_US = Adapalene

| pregnancy_AU = D
| pregnancy_US = C
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = OTC
| legal_US_comment = / [[prescription_drug|℞-only]]
| routes_of_administration = [[外用|外用]]

<!--Pharmacokinetic data-->
| bioavailability = 透皮吸收率很低
| excretion = [[胆汁|胆汁]]

<!--Identifiers-->
| CASNo_Ref = {{cascite}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 106685-40-9
| ATC_prefix = D10
| ATC_suffix = AD03
| PubChem = 60164
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00210
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54244
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1L4806J2QF
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01112
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 31174
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1265

<!--Chemical data-->
| C=28 | H=28 | O=3 
| molecular_weight = 412.52 g/mol
| smiles = O=C(O)c2ccc1cc(ccc1c2)c3cc(c(OC)cc3)C46CC5CC(CC(C4)C5)C6
| InChI = 1/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)
| InChIKey = LZCDAPDGXCYOEH-UHFFFAOYAE
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LZCDAPDGXCYOEH-UHFFFAOYSA-N
}}
'''阿达帕林'''（Adapalene）是第三代[[维A酸|维A酸]]类外用药物，主要用于治疗轻中度[[痤疮|痤疮]]，也被用来治疗[[毛囊角化症|毛囊角化症]]（非适应症型用药）和其他皮肤症状。<ref>{{cite journal | author = Rolewski S | title = Clinical review: topical retinoids | journal = Dermatol Nurs | volume = 15 | issue = 5 | pages = 447–50, 459–65 | year = 2003 | pmid = 14619325 | url = http://www.medscape.com/viewarticle/464026 | access-date = 2014-09-17 | archive-date = 2019-07-27 | archive-url = https://web.archive.org/web/20190727213205/https://www.medscape.com/viewarticle/464026 | dead-url = no }}</ref>

==历史==
[[File:Adapalene_Gel_(Differin)_in_China.jpg|left]]
阿达帕林1995年由法国{{link-en|高德美公司|Galderma}}研制，商品名为'''Differin'''（中国大陆译作'''达芙文'''，香港译作'''痘膚零'''，台灣译作'''痘膚潤'''）。

==作用机理==
阿达帕林通过抑制[[毛囊上皮细胞|毛囊上皮细胞]]的分化与增殖而减少微小粉刺形成，使表皮下的粉刺停止生長。阿达帕林可抑制[[多核白细胞|多核白细胞]]的化学[[趋化反应|趋化反应]]，通过抑制[[花生四烯酸|花生四烯酸]]经脂氧化反应转化为[[炎症介质|炎症介质]]来抑制多核白细胞的代谢。阿达帕林同[[维甲酸|维甲酸]]一样与特异的[[维甲酸核受体|维甲酸核受体]]结合，但不同的是阿达帕林不与和蛋白结合的细胞质受体相结合。

通过抑制角质形成细胞分化与增殖来产生抗痤疮作用。除了去角质作用外，其还具有[[抗炎|抗炎]]作用。

== 药理学 ==
[[File:Epiduo_sales_in_Singapore.jpg|thumb]]]]
===药物相互作用===
阿达帕林表现出可增强[[克林霉素|克林霉素]]在局部的作用，但[[副作用|副作用]]也一样增大。<ref name="Wolf">{{cite journal |author=Wolf JE, Kaplan D, Kraus SJ, ''et al.'' |title=Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study |journal=J Am Acad Dermatol |volume=49 |issue=3 Suppl |pages=S211–7 |year=2003 |pmid=12963897|doi=10.1067/S0190-9622(03)01152-6}}</ref>在使用克林霉素前3至5分钟使用阿达帕林凝胶可提高克林霉素的皮肤渗透率。相对单独使用克林霉素而言，合用可增强治疗的整体效果。<ref name="Jain">{{cite journal |author=Jain GK, Ahmed FJ |title=Adapalene pretreatment increases follicular penetration of clindamycin: in vitro and in vivo studies |journal=Indian J Dermatol Venereol Leprol |volume=73 |issue=5 |pages=326–9 |year=2007 |pmid=17921613 |doi=10.4103/0378-6323.34010}}</ref>

与[[维A酸|维A酸]]不同的是，阿达帕林已在同时使用[[过氧化苯甲酰|过氧化苯甲酰]]时表现出更好的化学结构稳定性。<ref>{{cite journal |author=Martin B, Meunier C, Montels D, Watts O |title=Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation |journal=Br J Dermatol |volume=139 Suppl 52 |issue= |pages=8–11 |date=October 1998|pmid=9990414 |doi= 10.1046/j.1365-2133.1998.1390s2008.x|url=}}</ref>

=== 药代动力学 ===
阿达帕林的透皮吸收率很低。一项研究表明6个每日使用一次的患者，连续5天使用10g/1000 cm²，其血浆中药物浓度无法检出或低于0.35 ng/mL。<ref name="productLabel">{{Cite web | title = DIFFERIN® (adapalene) Cream, 0.1% Label | publisher = FDA | date = May 25, 2000 | url = http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20748lbl.pdf | accessdate = 4 Oct 2011 | archive-date = 2017-02-16 | archive-url = https://web.archive.org/web/20170216121822/http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20748lbl.pdf | dead-url = no }}</ref>在体内主要分布于肝、脾、肾上腺和卵巢。主要通过氧-脱甲基、羟基化和结合反应代谢。主要通过胆汁排泄。

=== 毒理学 ===
阿达帕林在小鼠和大鼠中口服[[半数致死量|半数致死量]]大于10 ml/kg，长期使用会出现与维A酸类似的副作用。口服试验，雌性大鼠卵细胞性腺瘤与甲状腺癌发生率及雄性大鼠肾上腺髓质良性与恶性嗜铬细胞瘤发生率与使用量呈正线性相关。

==参考文献==
{{reflist}}

{{Acne Agents}}

[[Category:类视黄醇|Category:类视黄醇]]
[[Category:抗痤疮制剂|Category:抗痤疮制剂]]
[[Category:芳香醚|Category:芳香醚]]
[[Category:法国发明|Category:法国发明]]